Therefore, normal BM-MSCs injection restored the expression levels of SP-C, E-cadherin, and HGF and significantly decreased the expression levels of α-SMA, fibronectin, and TGF-β1 as compared with those in the BLM group. The gene discussed is FN1; the disease is Bloom syndrome.